Form 8-K · Current Report · Filed 2024-05-14
Stryker Corporation Shareholder Votes on Key Proposals
At the annual meeting held on May 9, 2024, Stryker Corporation shareholders re-elected all ten directors, ratified the appointment of Ernst & Young LLP as the independent auditor, approved the advisory vote on executive compensation, but rejected a proposal on political spending transparency.
- Filer
- Stryker Corporation SYK · NYSE
- Filed
- Accession
- 0000310764-24-000081
- CIK
- 0000310764
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Submission of Matters to a Vote of Security Holders
Market reaction
Close before filing
$324.56
Next session
+2.3%
Since filing
+0.4%
Latest close
$325.70
What happened, not what will happen — closing prices around the filing date.
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Never miss another SYK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.